About Hanmi
Hanmi is a company based in Seoul (South Korea) founded in 1973. The company has 2,390 employees as of December 31, 2024. Hanmi has completed 1 acquisition, including Aptose Biosciences.
- Headquarter Seoul, South Korea
- Employees 2390 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hanmi Pharmaceutical Co., Ltd.
-
Annual Revenue
$1.07 B (USD)3.48as on Dec 31, 2025
-
Net Profit
$130.14 M (USD)55.02as on Dec 31, 2025
-
EBITDA
$210.09 M (USD)-4.17as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
2390
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Hanmi
Hanmi is a publicly listed company on the KRX with ticker symbol 128940 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Hanmi
Detailed funding history for Hanmi
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hanmi
Hanmi has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aptose Biosciences.
Investment portfolio details for Hanmi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecules are developed for treating AML and high-risk MDS.
|
Locked | Locked | 1986 | Locked |
Complete acquisition details for Hanmi
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Hanmi
Detailed financials for Hanmi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hanmi Comparisons
Peer comparison for Hanmi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hanmi
Detailed competitors of Hanmi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hanmi
Complete news archive for Hanmi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hanmi
Hanmi was founded in 1973.
Hanmi is headquartered in Seoul, South Korea.
Se-Chang Kwon is the current CEO of Hanmi.
As of Dec 31, 2024, the latest employee count at Hanmi is 2,390.
Annual revenue of Hanmi is $1.07B as on Dec 31, 2025.
Detailed information about Hanmis operations, sectors, or solutions is not available from the provided content. The scope of their business activities remains unclear due to insufficient data on the website.
Yes, Hanmi is publicly traded on KRX under the ticker symbol 128940.
Hanmi has made 1 acquisition, including Aptose Biosciences.
The ticker symbol of Hanmi is 128940 on KRX.